Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Knowing what not to do as a new investor can save you time and money. Avoid common mistakes to build a successful investment portfolio.
28,184 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Discover how Remax RMAX 2025 earnings shape the company’s growth story. We break down revenue drivers, margins, and k...
Two investing legends, two starkly different takes on Amazon. This article breaks down the contrasting approaches, wh...
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
Pfizer stock is signaling a shift after years of underperformance. This article breaks down what’s changing, why it m...
A big investor just bought millions of Grindr shares after the stock plunged. This article breaks down why grindr sto...
ServiceNow has built a durable software platform with strong margins and steady growth. This article explains why the...
Are credit card cash rewards considered taxable income? Most personal rewards are not taxed, but there are important ...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
A wall street analyst just stirred a valuation debate around Palantir. This deep-dive breaks down what undervalued co...